01Jun 2024
Comparing Prognostic Utility of C-Alb and HCit in CKD Patients

Comparing Prognostic Utility of C-Alb and HCit in CKD Patients

This study compared serum C-Alb and free HCit in predicting outcomes in 1632 CKD patients from the CRIC study. Both markers were assessed for death and end-stage kidney disease (ESKD) risks using adjusted Cox models. C-Alb and HCit were correlated (r=0.64) and showed similar increased risks for death (HR: 1.90 for C-Alb, 1.89 for HCit) and ESKD. Prognostic metrics (C-statistics, NRI, IDI) were similar, indicating that C-Alb and HCit have comparable prognostic utility in CKD patients.

  • #nephrology

Like

Save

Share